Dr. Charles Damin Russo, MD

Dr. Russo practices at Holy Cross Health in Fort Lauderdale, Florida, part of Trinity Health.

Dr. Russo's NPI, 1588633614, was assigned on March 14, 2006. Dr. Russo graduated from New York Medical College in 1981. Dr. Russo holds Florida license ME0046573.

Dr. Russo's primary practice is Holy Cross Health, at 4725 N Federal Hwy, Fort Lauderdale, FL 33308 in Broward County. The practice phone is (954) 771-8000.

Dr. Russo's primary practice is Holy Cross Health in Fort Lauderdale, Florida, part of Trinity Health. The medical group on file is Holy Cross Medical Group. Dmand AI also links Dr. Russo to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Russo practices. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Russo's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Russo is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Russo is licensed in Florida.

Dmand AI lists aneurysm, aortic atherosclerois, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, chronic skin ulcer and coronary artery disease among the conditions Dr. Russo treats.

CMS data shows 112 Medicare services from Dr. Russo across 2 procedure codes in 2024, for 76 Medicare patients. Medicare paid $3,069 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 76 Medicare patients who saw Dr. Russo in 2024. The largest group is 75 to 84, with 31 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Russo's median patient age at 69, with 43% women.

In 2024, Dr. Russo wrote 360 Medicare Part D claims for 135 patients. 76% of them were for generic drugs. CMS names the drug for 239 of them, across 10 drugs with 11 or more claims each, at $81,192 in total drug cost. In 2023, CMS named 953 claims across 28 drugs.

Dr. Russo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Russo to 1 clinical trial. Conditions studied include Risk Reduction Behavior and Metabolic Syndrome.

CMS Open Payments shows 87 general payments to Dr. Russo from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $656.

Dmand AI lists 4 awards for Dr. Russo, most recently CMS Stage 1 EHR in 2012.

Dr. Russo graduated from New York Medical College in 1981. Dr. Russo is a member of ACC.

Dr. Russo is in network with 14 carriers, including Elevance, Excellus BlueCross BlueShield and Aetna. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.